Skip to main content
. 2019 Feb 20;20(6):397–408. doi: 10.2217/pgs-2018-0205

Table 3. . Logistic regression association between prescribing behavior and genotype.

Variable (A) Poor/ultrarapid N = 8 (%) (B) Reduced N = 32 (%) (C) Normal/indeterminate N = 62 (%) OR (95% CI) (A) v (C) OR (95% CI) (B) v (C) p-value
Alternate opioid prescribed by 30 days (Y) 3 (38) 3 (9) 3 (5) 15.1 (1.8–161.3) 2.3 (0.4–13.7) 0.04

Alternate opioid prescribed by 60 days (Y) 4 (50) 4 (12) 3 (5) 19.0 (2.8– 160.4) 2.9 (0.6– 16.2) 0.01

Alternate opioid prescribed by 90 days (Y) 4 (50) 8 (25) 7 (11) 9.5 (1.7– 57.3) 2.6 (0.8– 8.8) 0.03

Alternative opioid prescribed during follow-up (Y) 5 (63) 11 (34) 17 (27) 4.6 (0.9–25.9) 1.5 (0.6– 4.0) 0.16

Discontinuation of tramadol or codeine during follow-up (Y) 7 (88) 12 (38) 15 (24) 24.7 (3.6– 503.1) 1.9 (0.7– 5.1) 0.002

Dose change (Y) 1 (13) 4 (13) 13 (21) 0.6 (0.03– 4.6) 0.7 (0.2– 2.2) 0.79

Refill prescribed (Y) 0 (0) 14 (44) 30 (48) 0 (NA) 0.9 (0.3– 2.2) 0.01

All available follow-up (up to 1 year) was used to determine the outcome.

95% CI not available due to sample size.

OR: Odds ratio; Y: Yes or positive outcome.

All p-value calculations are based on a multivariate logistic regression model.